Longeveron's CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer's Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer's Association International Conference (AAIC)
Stocks in this Quantisnow insightHealth Care
Quantisnow market dataNASDAQ
LGVN
Longeveron Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2021
Get push alerts for LGVN
Full LGVN profile on Quantisnow Follow LGVN and get a push notification the moment its next story breaks.